A detailed history of Ancora Advisors, LLC transactions in Better Therapeutics, Inc. stock. As of the latest transaction made, Ancora Advisors, LLC holds 3,000 shares of BTTX stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,000
Previous 3,000 -0.0%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.01 - $0.02 $30 - $60
3,000 New
3,000 $0

Others Institutions Holding BTTX

# of Institutions
1
Shares Held
3K
Call Options Held
0
Put Options Held
0

About Better Therapeutics, Inc.


  • Ticker BTTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,743,000
  • Description
  • Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional ...
More about BTTX
Track This Portfolio

Track Ancora Advisors, LLC Portfolio

Follow Ancora Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ancora Advisors, LLC with notifications on news.